Diet and Well-being of Young Danish Children (SKOT I)

November 11, 2019 updated by: Arne Astrup, University of Copenhagen

The SKOT I Cohort - a Prospective Cohort Study of Diet and Well-being in Young Danish Children

The overall objective with the study was to contribute to the scientific basis for dietary and life strategies, policies and dietary guidelines to infants and young children in Denmark and with special focus on prevention of obesity and diet related chronic diseases such as type 2 diabetes, ischemic heart disease and osteoporosis.

Study Overview

Detailed Description

The SKOT I study is a prospective cohort study monitoring healthy young children from 9 to 36 months of age. In 2007, 2211 families from Copenhagen were randomly selected through the National Civil Registry and invited to participate in the study by letter. The participants were invited to three examinations at 9 months ±2 weeks, 18 months ±4 weeks and 36 months ±3 months. A total of 330 children are included in the study, where 312 have completed the 9 months examination, 291 completed the 18 months examination and 263 completed the 3-year examination. All examinations took place at Department of Nutrition, Exercise and Sports, Frederiksberg Denmark. The examinations involved collecting a broad spectrum of data. Following data were collected: anthropometry (weight, height, age- and sex-specific Z-scores for body composition, triceps and subscapularis skinfolds), background interview (concerning e.g. infant feeding, household income, the parent's educational level, allergy and chronic diseases), blood pressure (systolic, diastolic and mean arterial pressure), faeces- and urine sample, blood samples (9 and 36 months), Bio impedance analysis (36 months), 7 day diet registration, general questionaire (concerning e.g. sleep, daycare, attendance and use of screen devices), psychomotor questionnaire (motoric development), 7 day physical activity monitoring and dual energy x-ray absorptiometry scan (36 months).

Study Type

Observational

Enrollment (Actual)

263

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Frederiksberg, Denmark, 1958
        • Department of Human Nutrition, Faculty of Sciences, University of Copenhagen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 months to 3 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy young Danish Children selected through the National Civil Registry and invited to participate by letter.

Description

Inclusion Criteria:

  • healthy singletons born at term (week 37-43) between August 2006 and September 2007 with no disease that could influence food intake or growth

Exclusion Criteria:

  • born preterm (before week 37)
  • non-Danish speaking parents.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
growth and development
Growth and development of a random sample of healthy Danish infants

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in anthropometric measurements in periods of early childhood.
Time Frame: 9, 18 and 36 months of age
Composite outcome consisting of body weight, height, body mass index (BMI) and BMI z-scores, waist-, upper arm- and head circumference, skinfold thickness measured at subscapularis and triceps.
9, 18 and 36 months of age
Body composition in early childhood
Time Frame: 36 months of age
Body composition is measures by Dual-energy X-ray Absorptiometry and bio impedance. Fat mass, fat mass index (kg/m2), fat free mass index (kg/m2) are calculated.
36 months of age
Metabolic syndrome score in early life
Time Frame: 9 and 36 months of age
Composite outcome consisting of triglycerides, high lipoprotein (HDL) and glucose measured in plasma/serum, waist circumference and blood pressure.
9 and 36 months of age
Diet in periods of early life
Time Frame: 9, 18 and 36 months of age
The diet is recorded using self-reported 7-day record questionnaire.
9, 18 and 36 months of age

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Breastfeeding duration in infancy and early childhood
Time Frame: 9, 18 and 36 months of age
Questionnaire used for assessment of exclusive and partially breastfeeding.
9, 18 and 36 months of age
Insulin like growth factor at 9 and 36 months of age
Time Frame: 9 and 36 months of age
Insulin like growth factor-1 and insulin like growth factor binding protein-3 concentrations in plasma.
9 and 36 months of age
Physical activity, sedentary behavior and sleep in early childhood
Time Frame: 9, 18 and 36 months of age
Physical activity and sedentary behavior measured by ActiGrafph GT3X accelerometer, recording for 24 hours in 7 days at 36 months of age. Information on outdoor activity, sedentary behavior and night sleep are collected through questionnaires at 9, 18 and 36 months of age.
9, 18 and 36 months of age
Bone mass in 3-year-old children
Time Frame: 36 months of age
Bone mass is measured by Dual-energy X-ray Absorptiometry
36 months of age
Vitamin D status in infancy
Time Frame: 9 months of age
25-hydroxyvitamin D concentrations are analysed in blood samples at 9 months of age.
9 months of age
Allergy and chronic diseases
Time Frame: 9 and 36 months of age
Assessment of diseases by questionnaires
9 and 36 months of age
Appetite hormones in infancy
Time Frame: 9 months of age
Leptin and adiponectin concentrations measured from blood samples
9 months of age
Change in gut microbiota
Time Frame: 9, 18 and 36 months of age
Microbiota in the faeces analysed using polymerase chain reaction (PCR)
9, 18 and 36 months of age
Achievement of milestones
Time Frame: 9 and 36 months of age
Achievement of age-specific milestones by questionnaires; WHO questionnaires at 9 and 36 months of age and Ages & Stages Questionnaires (ASQ) at 36 months of age
9 and 36 months of age
Metabolomics in the urine
Time Frame: 9, 18 and 36 months of age
Metabolomics analysed using urine samples.
9, 18 and 36 months of age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kim F Michaelsen, MD Professor, Faculty of Science, University of Copenhagen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2007

Primary Completion (Actual)

October 1, 2010

Study Completion (Actual)

October 1, 2010

Study Registration Dates

First Submitted

June 4, 2014

First Submitted That Met QC Criteria

June 17, 2014

First Posted (Estimate)

June 23, 2014

Study Record Updates

Last Update Posted (Actual)

November 13, 2019

Last Update Submitted That Met QC Criteria

November 11, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • D201
  • H-KF-2007-0003 (Other Identifier: The Committees on Biomedical Research Ethics for the Capital Region of Denmark)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Growth Acceleration

Subscribe